LakeShore Biopharma Co., Ltd (LSB) — Financial Flexibility Index
Latest as of June 2022:
-0.01x
LakeShore Biopharma Co., Ltd (LSB) has a Financial Flexibility Index of -0.01x as of June 2022. Free cash flow of $-693.96K (operating CF $-693.96K minus capex $0.00) represents 0% of total liabilities ($76.38 Million).
Financial Flexibility Index
-0.01x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-693.96K
Operating CF − Capex
Total Liabilities
$76.38 Million
USD
Capital Expenditures
$0.00
USD
LakeShore Biopharma Co., Ltd Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for LakeShore Biopharma Co., Ltd across 5 annual periods. See working capital position of LakeShore Biopharma Co., Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for LakeShore Biopharma Co., Ltd (2021–2025)
Year-by-year free cash flow to debt coverage for LakeShore Biopharma Co., Ltd. For the full company profile including market capitalisation, see LSB market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-103.12 Million | $-120.98 Million | $867.91 Million | ▲ +56.1% |
| 2024 | -0.27x | $-250.98 Million | $-295.23 Million | $927.82 Million | ▼ -113.8% |
| 2023 | -0.13x | $-125.42 Million | $-182.47 Million | $991.30 Million | ▼ -102.1% |
| 2022 | 6.16x | $125.39 Million | $-173.55 Million | $20.35 Million | ▲ +100.3% |
| 2021 | -2024.38x | $-141.73 Million | $-246.61 Million | $70.01K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities